» Authors » Serap Akyurek

Serap Akyurek

Explore the profile of Serap Akyurek including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 281
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gumustepe E, Yavas G, Kirakli E, Dincbas F, N D, Hurmuz P, et al.
Am J Clin Oncol . 2024 Oct; 48(2):67-74. PMID: 39434398
Objectives: The aim of this retrospective multicenter study was to evaluate the prognostic significance of low muscle mass, and inflammatory markers in patients with stage III nonsmall cell lung cancer...
2.
Guler O, Hurmuz P, Atalar B, Guney Y, Kaytan Saglam E, Akyurek S, et al.
Strahlenther Onkol . 2024 Aug; 200(11):958-966. PMID: 39158748
Purpose: To investigate the treatment outcomes of extracranial oligometastatic colorectal cancer (CRC) patients treated with stereotactic body radiotherapy (SBRT). Materials And Methods: The clinical data of 388 extra-cranial oligometastatic CRC...
3.
Gumustepe E, Akyurek S
Int J Radiat Oncol Biol Phys . 2024 Aug; 120(1):301. PMID: 39147435
No abstract available.
4.
Alkan A, Mizrak D, Yasar A, Karci E, Koksoy E, Urun M, et al.
J Cancer Res Ther . 2024 Jul; 20(3):913-917. PMID: 39023597
Introduction: Adjuvant chemoradiotherapy (CRT) is the optimal management strategy in resectable gastric cancer. There is a debate about the efficacy of more aggressive CRT plus chemotherapy regimens in adjuvant setting....
5.
Kahraman S, Karakaya S, Kaplan M, Sezgin Goksu S, Ozturk A, Isleyen Z, et al.
Sci Rep . 2024 Mar; 14(1):5820. PMID: 38461209
Central nervous system (CNS) metastases can be seen at a rate of 30% in advanced stages for patients with non-small cell lung cancer (NSCLC). Growing evidence indicates the predictive roles...
6.
Sert F, Gorken I, Ozkok S, Oksuz D, Yucel B, Kaytan Saglam E, et al.
Asian J Surg . 2024 Mar; 47(7):3056-3062. PMID: 38443256
Objectives: We aimed to develop a basic, easily applicable nomogram to improve the survival prediction of the patients with stage II/III gastric cancer (GC) and to select the best candidate...
7.
Duru Birgi S, Ozkaya Akagunduz O, Dagdelen M, Yazici G, Canyilmaz E, Ceylaner Bicakci B, et al.
Am J Clin Oncol . 2024 Feb; 47(6):279-288. PMID: 38390915
Objectives: This study aims to examine the treatment outcomes and related factors in locally advanced sinonasal cancer across Turkiye. Methods: Twelve centers participants of the Turkish Society for Radiation Oncology...
8.
Duru Birgi S, Akyurek S, Birgi E, Arslan Y, Gumustepe E, Bakirarar B, et al.
Head Neck . 2023 Sep; 45(11):2907-2914. PMID: 37740459
Purpose: We aimed to describe the association between trigeminal nerve (TN) dose and toxicity and determine a threshold value that leads to TN toxicity in patients with parotid tumors treated...
9.
Guler O, Oymak E, Yazici G, Ozkaya Akagunduz O, Cetinayak O, Erpolat P, et al.
Oncol Res . 2023 Jun; 31(3):299-306. PMID: 37305394
The aim of this study was to examine the prognostic factors and treatment outcomes of cervical esophageal carcinoma (CEC) patients who underwent definitive chemoradiotherapy (CRT). The clinical data of 175...
10.
Kayi Cangir A, Yumuk P, Dizbay Sak S, Akyurek S, Eralp Y, Yilmaz U, et al.
J Thorac Oncol . 2022 Oct; 17(10):1158-1170. PMID: 36192076
No abstract available.